No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3139 |
4. Check minimum number of eventsNone |
3139 |
5. Include endpointsNone |
3139 |
6. Filter based on genotype QC (FinnGen only) |
3009 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Similar endpoints
↥List of similar endpoints to Benign neoplasm: Transverse colon based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Transverse colon
- Benign neoplasm: Colon
- Benign neoplasm: Colon
- Benign neoplasm of colon, rectum, anus and anal canal
- Benign neoplasm of colon, rectum, anus and anal canal
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 16587 | 7441 | 9089 |
Only index persons | 15795 | 7174 | 8621 |
Unadjusted period prevalence (%) | |||
Whole population | 0.23 | 0.21 | 0.25 |
Only index persons | 0.30 | 0.26 | 0.33 |
Median age at first event (years) | |||
Whole population | 68.07 | 67.76 | 68.33 |
Only index persons | 67.93 | 67.60 | 68.21 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 3009 | 1340 | 1669 |
Unadjusted period prevalence (%) | 0.70 | 0.53 | 0.84 |
Median age at first event (years) | 67.59 | 66.45 | 68.51 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_TRANSVERSE_COLON and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_TRANSVERSE_COLON | 1.299 [1.16, 1.46] | < 0.001 |
Birth year | 1.0 [0.99, 1.01] | 0.947 |
During the follow-up period (1.1.1998 — 31.12.2019), 1139 out of 5873 females with CD2_BENIGN_TRANSVERSE_COLON died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_TRANSVERSE_COLON | 1.36 [1.21, 1.53] | < 0.001 |
Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 2006 out of 7240 males with CD2_BENIGN_TRANSVERSE_COLON died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_TRANSVERSE_COLON.N-year risk | Females | Males |
---|---|---|
1 | 0.122% | 0.234% |
5 | 0.829% | 1.35% |
10 | 2.124% | 3.367% |
15 | 4.219% | 6.235% |
20 | 7.572% | 10.785% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_TRANSVERSE_COLON – Benign neoplasm: Transverse colon
GWS hits: -